Correspondence 0001104659-24-012958 from Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc.
Date: Feb. 9, 2024 · CIK: 0001477845 · Accession: 0001104659-24-012958
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276814
Letter
VIA EDGAR Division of Corporation Finance Attention: Daniel Crawford Re: Annovis Bio, Inc. Registration Statement on Form S-3 File No. 333-276814
Dear Mr. Crawford:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the registrant Annovis Bio, Inc.. hereby requests acceleration of effectiveness of the above-referenced Registration Statement so that it will become effective at 4:15 p.m. ET on Monday, February 12, 2024, or as soon as practicable thereafter.
Very truly yours,
ANNOVIS BIO, INC.
Show Raw Text
CORRESP
1
filename1.htm
Annovis Bio, Inc.
101 Lindenwood Drive, Suite 225
Malvern, PA 19355
Tel: (484) 875-3192
February 9, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Daniel Crawford
Re: Annovis Bio, Inc.
Registration Statement on Form S-3
File No. 333-276814
Dear Mr. Crawford:
Pursuant to Rule 461 under the Securities Act of 1933, as amended,
the registrant Annovis Bio, Inc.. hereby requests acceleration of effectiveness of the above-referenced Registration Statement so
that it will become effective at 4:15 p.m. ET on Monday, February 12, 2024, or as soon as practicable thereafter.
Very truly yours,
ANNOVIS BIO, INC.
By:
/s/ Henry Hagopian III
Name:
Henry Hagopian III
Title:
Chief Financial Officer